Cat’s Claw, MGM-15 & Kratom in Kentucky: 2026 Warning

On September 14, 2026, WSMV 4 Nashville reported that the Tennessee Bureau of Investigation was warning consumers and retailers about products marketed as Cat’s Claw.

According to TBI, authorities were seeing an increase in products carrying that name that actually contained MGM-15.

TBI described MGM-15 as a compound made from kratom and warned consumers not to assume that a product is safe or legal based only on its packaging.

The warning is particularly relevant for communities near the Kentucky-Tennessee border because retail products and emerging drug trends do not necessarily remain confined to one state.

Kentucky Recovery Center is located in Franklin, Kentucky, along the I-65 corridor between Bowling Green and Nashville.

That makes developments in Tennessee’s drug market relevant to families throughout southern Kentucky.

The name itself can create confusion.

Cat’s claw commonly refers to plants in the Uncaria genus, including vines native to Central and South America.

Kratom comes from Mitragyna speciosa, a different plant native to Southeast Asia.

The Tennessee warning therefore does not mean every botanical supplement labeled Cat’s Claw contains kratom or MGM-15.

The concern involves certain products marketed using the Cat’s Claw name that authorities say contain kratom-related compounds.

This distinction is important because someone may believe they are taking one type of botanical product while actually consuming something with very different psychoactive properties.

MGM-15 is one of several kratom-related compounds receiving increased attention from state and federal authorities.

Federal health officials identify MGM-15 as dihydro-7-hydroxymitragynine.

In July 2026, the U.S. Drug Enforcement Administration began the temporary scheduling process for certain kratom-related substances.

That federal action included:

The FDA has emphasized that these synthetic derivatives are not naturally occurring components of the kratom plant in the same way consumers may encounter naturally occurring kratom alkaloids.

This is one reason it is important not to use the terms kratom, 7-OH and MGM-15 interchangeably.

Understanding a few basic terms can make the current warnings easier to follow.

Its naturally occurring alkaloids include mitragynine and smaller amounts of 7-hydroxymitragynine.

Concentrated 7-OH products have received significant regulatory attention because they can contain concentrations very different from those naturally occurring in kratom leaf.

These distinctions matter clinically.

Someone entering treatment should tell healthcare professionals as much as possible about the specific products they have been using rather than simply saying they have been taking “kratom.”

The Tennessee warning illustrates a larger problem that applies beyond one state’s borders:

A product’s branding may not tell consumers everything they need to know about its contents.

Products can move through online marketplaces, convenience stores, smoke shops and regional distribution networks.

A consumer may encounter terms such as:

Seeing one of these terms does not automatically establish whether a particular product is legal, illegal, naturally derived or synthetic.

It does mean consumers should pay close attention to the ingredient list and avoid assuming that unfamiliar branding accurately describes a product’s pharmacological contents.

If you have regularly used kratom, 7-OH, MGM-15 or a product sold under another name, start by looking at what happens when you delay or skip a dose.

Physical dependence can develop when the body adapts to repeated exposure to a substance.

Possible warning signs include:

Kentucky Recovery Center provides kratom detox in Kentucky for people who need structured support while stopping regular kratom or concentrated-product use.

Kratom withdrawal is different for everyone.

The experience can depend on the amount used, frequency of use, length of use, concentration of the product, previous opioid dependence and whether alcohol or other drugs are also involved.

Some people describe kratom withdrawal as resembling opioid withdrawal.

The intensity varies considerably, particularly when extracts or concentrated products are involved.

There is no universal kratom withdrawal timeline.

People who take kratom several times per day may begin noticing symptoms within hours of missing a dose, while others may experience a slower onset.

A general pattern can include:

The specific product matters.

Someone using concentrated 7-OH or another kratom-derived compound may not have exactly the same experience as someone using traditional kratom powder.

When someone arrives for detox, one of the first questions is what substances they have been taking.

That becomes more difficult when the answer is uncertain.

Someone may think they were taking ordinary kratom but have actually been using a concentrated extract.

Another person may have been purchasing a product marketed under a completely different name.

Others may combine kratom-related products with:

• Alcohol
• Prescription opioids
• Fentanyl
• Benzodiazepines
• Stimulants
• Prescription medications

These combinations can change the withdrawal picture and the appropriate level of medical monitoring.

Keeping the original packaging can be useful when seeking treatment because it may provide clinicians with additional information about ingredients, concentrations or serving sizes.

Some people begin using kratom because they are trying to reduce or stop prescription opioids, heroin or fentanyl.

At first, kratom may appear to reduce withdrawal discomfort.

Over time, however, a person can begin relying on kratom itself.

They may eventually find that they need kratom every morning, use it repeatedly throughout the day or experience withdrawal when they try to stop.

For someone with a history of opioid use disorder, another concern is relapse.

If kratom has been suppressing opioid cravings or withdrawal symptoms, stopping it without addressing the underlying opioid-use history can leave the person vulnerable to returning to fentanyl, heroin or prescription opioids.

Treatment planning should therefore look beyond the substance currently being used.

Kentucky Recovery Center provides structured kratom detox in Kentucky based on each client’s symptoms and history.

Treatment begins with an assessment.

The clinical team may consider:

During detox, the treatment team can monitor symptoms and provide individualized support as the body adjusts.

The goal is not simply to stop the substance.

It is to create enough stability to move into the next phase of recovery.

Withdrawal management addresses the immediate physical transition away from a substance.

It does not automatically address why use became difficult to control.

Someone may have originally turned to kratom for pain.

Another person may have been trying to manage anxiety or depression.

Someone else may have used it to avoid opioid withdrawal.

Those underlying concerns can remain after detox.

Continued treatment may involve residential care, therapy, dual-diagnosis treatment, family support, relapse-prevention planning and other services based on individual needs.

Kentucky Recovery Center also offers kratom rehab in Kentucky for people who need continued treatment after withdrawal stabilization.

Kentucky Recovery Center is located in Franklin, Kentucky, serving people from throughout southern Kentucky and the surrounding region.

Our Franklin campus provides a structured treatment environment where clients can focus on stabilization and recovery away from the routines and environments associated with substance use.

Kentucky Recovery Center is located at:

1119 Brookhaven Road
Franklin, KY 42134

Our admissions team can discuss symptoms, treatment needs, insurance benefits and the appropriate next step.